MONTREAL and CHARLOTTE, N.C., Nov. 11, 2020 /PRNewswire/ -- Milestone
Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical
company focused on the development and commercialization of
innovative cardiovascular medicines, today announced
that Joseph Oliveto, President and Chief Executive Officer,
will present at the Jefferies Virtual London Healthcare Conference
on Wednesday, November 18, 2020 at 7:55 AM ET. The
conference will be held in a virtual meeting format.
A live webcast of the presentation can be accessed in the News
& Events section of Milestone's website
at www.milestonepharma.com. An archived replay of the webcast
will be available on the same website for approximately 30 days
following the presentation.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals is a biopharmaceutical company
focused on the development and commercialization of etripamil, a
Phase 3 clinical-stage program, for the treatment of cardiovascular
indications. Milestone Pharmaceuticals operates
in Canada and the United States. For more
information, visit www.milestonepharma.com and follow the
Company on Twitter at @MilestonePharma.
Contact
David Pitts
Argot Partners
212-600-1902
david@argotpartners.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-the-jefferies-virtual-london-healthcare-conference-301170433.html
SOURCE Milestone Pharmaceuticals, Inc.